Glutamate hypothesis of schizophrenia and approach for possible therapeutic drugs

Current Medicinal Chemistry - Central Nervous System Agents

Volumn 4, Issue 2, 2004, Pages 147-154

  Hashimoto, Kenji ^a   Okamura, Naoe ^a   Shimizu, Eiji ^a   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

AMPA receptor; Antipsychotic drugs; D Serine; Glutamate; Glycine transporter inhibitor; Metabotropic glutamate receptor; NMDA receptor; Schizophrenia

Indexed keywords

2 (2,3 DICARBOXYCYCLOPROPYL)GLYCINE; 2 AMINO 4 PHOSPHONOBUTYRIC ACID; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; ALX 5407; AMPA RECEPTOR; CHLORPROMAZINE; CLOZAPINE; DIZOCILPINE; EGLUMETAD; EXCITATORY AMINO ACID; GLUTAMATE 2 RECEPTOR AGONIST; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID; GLYCINE TRANSFER RNA; GLYCINE TRANSPORTER INHIBITOR; HALOPERIDOL; KETAMINE; MGS 0008; MGS 0028; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; PHENCYCLIDINE; QUETIAPINE; RECEPTOR SUBTYPE; RISPERIDONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; Y 931; ZOTEPINE;

ALLOSTERISM; AMINO ACID METABOLISM; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; DRUG BINDING SITE; DRUG RELEASE; HUMAN; NERVE CELL; NERVE FIBER GROWTH; NERVOUS SYSTEM FUNCTION; NEUROTRANSMISSION; PATHOPHYSIOLOGY; REVIEW; SCHIZOPHRENIA;

EID: 2442614201     PISSN: 15680150     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568015043357011     Document Type: Review

References (82)

1. Carlsson, A.; Waters, N.; Holm-Waters, S.; Tedroff, J.; Nilsson, M.; Carlsson, M.L.; Annu. Rev. Pharmacol. Toxicol., 2001, 41, 237-260.
2. Meador-Woodruff, J.H.; Kleinman, J.E. In Neuropsychopharmacology -The Fifth generation of Progress-. Davis, K.L.; Charney, D.; Coyle, J.T.; Nemeroff, C. Ed.; Lippincott Williams & Wilkins: Philadelphia, 2002; 717-728.
3. Javitt, D.C.; Zukin, S.R. Am. J. Psychiatry, 1991, 148, 1301-1308.
4. Coyle, J.T. Harv. Rev. Psychiatry, 1996, 3, 241-253.
5. Olney, J.W.; Farber, N.B. Arch. Gen. Psychiatry, 1995, 52, 998-1007.
6. Tamminga, C.A. Cri. Rev. Neurobiol., 1998, 12, 21-36.
7. Aghajanian, G.K.; Marek, G.J. Brain Res. Rev., 2000, 31, 302-312.
8. Goff, D.C.; Coyle, J.T. Am. J. Psychiatry, 2001, 158, 1367-1377.
9. Hashimoto, K.; Iyo, M. Jpn. J. Neuropsychopharmacol., 2002, 22, 3-13.
10. Tsai, G.; Coyle, J.T. Annu. Rev. Pharmacol. Toxicol., 2002, 42, 165-179.
11. Luby, E.D.; Cohen, B.D.; Rosenbaum, G.; Gottilieb, J.S.; Kelly, R. Arch. Neurol. Psychiatry, 1959, 81, 363-369.
12. Allen, R.M.; Young, S.J. Am. J. Psychiatry. 1978, 135: 1081-1084.
13. Krystal, J.H.; Karper, L.; Pseibyl, J.P.; Freeman, G.K.; Delaney, R.; Bremmer, J.D.; Heninger, G.R.; Bowers, M.B.; Charney, D.S. Arch. Gen. Psychiatry, 1994, 51, 199-214.
14. Kane, J.; Honigfeld, G.; Singer, J.; Meltzer, H. Arch. Gen. Psychiatry, 1988, 45, 789-96.
15. Buchanan, R.W. Schizophr. Res., 1995, 21, 579-591.
16. Borison, R.L. Harv. Rev. Psychiatry, 1997, 4, 255-271.
17. Kane, J.M.; McGlashan, T.H. Lancet, 1995, 346, 820-825.
18. Meltzer, H.Y.; Park, S.; Kessler, R. Proc. Natl. Acad. Sci. USA, 1999, 96, 13591-13593.
19. Miller, D.D. J. Clin. Psychiatry, 2000, 61 (suppl 8), 14-17.
20. Remington, G.; Kapur, S. Psychopharmacol., 2000, 49, 3-15.
21. Jentsch, J.D.; Roth, R.H. Neuropsychopharmacol., 1999, 20, 201-225.
22. Gainetdinov, R.R.; Mohn, A.R.; Caron, M.G. Trends Neurosci., 2001, 24, 527-533.
23. Olney, J.W.; Labruyere, L.; Price, M.T. Science, 1989, 244, 1360-1362.
24. Olney, J.W.; Labruyere, L.; Wang, G.; Wozniak, D.F.; Price, M.T.; Sesma, M.A. Science, 1991, 254, 1515-1518.
25. Maddock, R.J. Trends Neurosci., 1999, 22, 310-316.
26. Farber, N.B.; Foster, J.; Olney, J.W. Schizophr. Res., 1996, 21, 33-37.
27. Fujimura, M.; Hashimoto, K.; Yamagami, K. Eur. J. Pharmacol., 2000, 398, 1-10.
28. Hashimoto, K.; Fujimura, M.; Yamagami, K. Life Sci., 2000, 66, 1071-1078.
29. Okamura, N.; Hashimoto, K.; Kanahara, N.; Shimizu, E.; Kumakiri, C.; Komatsu, N.; Iyo, M. Eur. J. Pharmacol., 2003, 461, 93-98.
30. Olney, J.W.; Newcomer, J.W.; Farber, N.B. J. Psychi. Res., 1999, 33, 523-533
31. Morimoto, T.; Hashimoto, K.; Yasumatsu, H.; Tanaka, H.; Fujimura, M.; Kuriyama, M.; Kimura, K.; Takehara, S.; Yamagami, K. Neuropsychopharmacol., 2002, 26, 456-467.
32. Fischer, V.; Haar, J.A.; Greiner, L.; Lloid, R.V.; Mason, R.P. Mol. Pharmacol. 1991, 40, 846-853.
33. Kohara, T.; Koyama, T.; Fujimura, M.; Tanaka, H.; Maeda, J.; Fujimoto, T.; Yamamoto, I.; Arita, M. Chem. Pharm. Bull., 2002, 50, 818-812.
34. Arvanov, V.L.; Liang, X.; Schwartz, J.; Grossman, S.; Wang, R.Y. J. Pharmacol. Exp. Ther., 1997, 283, 226-234.
35. Wang, R.Y.; Liang, X.; Jadermark, K.E.; Arvanov, V. In Olanzapine (Zyprexa)- a novel antipsychotic-. Tran, P.V.; Bymaster, F.; Tye, N.; Herrera, J.; Breier, A.; Tollefson, G. Ed.; Williams & Wilkins: Baltimore, 2000; 114-131.
36. Ninan, I.; Jadermark, K.E.; Wang, R.Y. Synapse, 2003, 48, 66-79.
37. Jadermark, K.E.; Ai, J.; Ninan, O.; Wang, R.Y. Synapse, 2001, 41, 294-300.
38. Coyle, J.T.; Leski, M.L.; Morrison, J.H. In Neuropsychopharmacology -The Fifth generation of Progress-. Davis, K.L.; Charney, D.; Coyle, J.T.; Nemeroff, C. Ed.; Lippincott Williams & Wilkins: Philadelphia, 2002; 71-90.
39. Bergeron, R.; Meyer, T.M.; Coyle, J.T.; Greene, R.W. Proc. Natl. Acad. Sci. USA, 1998, 95, 15730-15734.
40. Javitt, D.C.; Zylberman, I.; Zukin, S.R.; Heresco-Levy, U.; Lindenmayer, J.P. Am. J. Psychiatry, 1994, 151, 1234-1236.
41. Heresco-Levy, U.; Javitt, D.C.; Ermilov, M.; Mordel, C.; Horowitz, A.; Kelly, D. Br. J. Psychiatry. 1996, 169, 610-617.
42. Heresco-Levy, U.; Javitt, D.C.; Ermilov, M.; Mordel, C.; Silipo, G.; Lichtenstein, M. Arch. Gen. Psychiatry, 1999, 56, 29-36.
43. Goff, D.C.; Tsai, G.; Manoach, D.S.; Coyle, J.T. Am. J. Psychiatry, 1995, 152: 1213-1215.
44. Goff, D.C.; Tsai, G.; Manoach, D.S.; Flood, J.; Darby, D.G.; Coyle, J.T. Am. J. Psychiatry, 1996, 153, 1628-1630.
45. van Berckel, B.N.; Hijman, R.; van der Linden, J.A.; Westenberg, H.G.; van Ree, J.M.; Kahn, R.S. Biol. Psychiatry, 1996, 40, 1298-1300.
46. van Berckel, B.N.; Evenblij, C.N.; van Loon, B.J.; Maas, M.F.; van der Geld, M.A.; Wynne, H.J.; van Ree, J.M.; Kahn, R.S. Neuropsychopharmacology, 1999, 21, 203-210.
47. Evins, A.E.; Amico, E.; Posever, T.A.; Toker, R.; Goff, D.C. Schizophr. Res. 2002, 56, 19-23.
48. Snyder, S.H.; Ferris, C.D. Am. J. Psychiatry, 2000, 157, 1738-1751.
49. Snyder, S.H.; Kim, P.M. Neurochem. Res., 2000, 25, 553-560.
50. Wolosker, H.; Panizzutti, R.; De Miranda, J. Neurochem. Int., 2002, 41, 327-32.
51. Tsai, G.; Yang, P.; Chung, L.C.; Lange, N.; Coyle, J.T. Biol. Psychiatry, 1998, 44, 1081-1089.
52. Hashimoto, K.; Fukushima, T.; Shimizu, E.; Komatsu, N.; Watanabe, H.; Shinoda, N.; Nakazato, M.; Kumakiri, C.; Okada, S.; Hasegawa, H.; Imai, K.; Iyo, M. Arch. Gen. Psychiatry, 2003, 60, 572-576.
53. Lopez-Corcuera, B.; Aragon, C. Geerlings, A. Biochem. Soc. Trans. 2001, 29, 742-745.
54. Gadea, A.; Lopez-Colome, A.M. J. Neurosci. Res. 2001, 64, 218-222.
55. Supplisson, S.; Roux, M.J. FEBS Lett. 2002, 529, 93-101.
56. Miyamoto, S.; Duncan, G.E.; Goff, D.C.; Lieberman, J.A. In Neuropsychopharmacology -The Fifth generation of Progress-. Davis, K.L.; Charney, D.; Coyle, J.T.; Nemeroff, C. Ed.; Lippincott Williams & Wilkins: Philadelphia, 2002; 775-807.
57. Atkinson, B.N.; Bell, S.C.; De Vivo, M.; Kowalski, L.R.; Lechner, S.M.; Ognyanov, V.I.; Tham, C.S.; Tsai, C.; Jia, J.; Ashton, D.; Klitenick, M.A. Mol. Pharmacol., 2001, 60, 1414-1420.
58. Chen, L.; Muhlhauser, M; Yang, C.R. J. Neurophysiol., 2003, 89, 691-703.
59. Javitt, D.C.; Sershen, H.; Hashim, A.; Lajtha, A. Neuropsychopharmacol., 1997, 17, 202-204.
60. Javitt, D.C.; Frusciante, M. Psychopharmacol., 1997, 129, 96-98.
61. Javitt, D.C.; Balla, A.; Sershen, H.; Lajtha, A. Biol. Psychiatry, 1999, 45, 668-679.
62. Cartmell, J.; Schoepp, D.D.: J. Neurochem., 2000, 75, 889-907.
63. De Blasi, A.; Conn, P.J.; Pin, J.-P.; Nicoletti, F. Trends Pharmacol. Sci., 2001, 22, 114-120.
64. Moghaddam, B.; Adams, B.W. Science, 1998, 281-1349-1352.
65. Cartmell, J.; Monn, J.; Schoepp, D.D. J. Pharamacol. Exp. Ther., 1999, 291, 161-170.
66. Cartmell, J.; Perry, K.W.; Salhoff, C.R.; Monn, J.A.; Schoepp, D.D. Neuropharmacology, 2001, 40, 847-855.
67. Swanson, C.J.; Schoepp, D.D. J. Pharmacol. Exp. Ther., 2002, 303, 919-927.
68. Nakazato, A.; Kumagai, T.; Sakagami, K.; Yoshikawa, R.; Suzuki, Y.; Chaki, S.; Ito, H.; Taguchi, T.; Nakanishi, S.; Okuyama, S. J. Med. Chem., 2000, 43, 4893-4909.
69. Staubli, U.; Rogers, G.; Lynch, G. Proc. Natl. Acad. Sci. USA, 1994, 91. 777-781.
70. Arai, A.; Kessler, M.; Rogers, G.; Lynch, G. J. Pharamacol. Exp. Ther., 1996, 278, 627-638.
71. Arai, A.; Kessler, M.; Rogers, G.; Lynch, G. Mol. Pharamacol., 2000, 58, 802-813.
72. Lynch, G. Nature Neurosci., 2002, 5, 1035-1038.
73. Johnson, S.A.; Luu, N.T.; Herbst, T.A.; Knapp, R.; Lutz, D.; Arai, A.; Rogers, G.A.; Lynch, G. J. Pharmacol. Exp. Ther., 1999, 289, 392-397.
74. Goff, D.C.; Leahy, L.; Berman, I.; Posever, T.; Herz, L.; Leon, A.C.; Johnson, S.A.; Lynch, G. J. Clin. Psychopharmacol. 2001, 21, 484-487.
75. Sekiguchi, M.; Fleck, M.W., Mayer, M.; Takeo, J.; Chiba, Y.; Yamashita, S.; Wada, K. J. Neurosci.. 1997, 17. 5760-5771.
76. Baumbarger, P.J.; Muhlhauser, M.; Zhai, J.; Yang, C.R.; Yang, C.R.; Nisenbaum, E.S. J. Pharmacol. Exp. Ther., 2001, 298, 86-102.
77. Vandergriff, J.; Huff, K.; Bond, A.; Lodge, D. Neuropharmacology, 2001, 40, 1003-1009.
78. Quirk, J.C.; Nisenbaum, E.S. CNS Drug Rev., 2002, 8, 255-282.
79. Chumakov, I.; Blumenfeld, M.; Guerassimenko, O.; Cavarec, L.; Palicio, M.; Abderrahim, H.; Bougueleret, L.; Barry, C.; Tanaka, H.; La Rosa, P.; Puech, A.; Tahri, N.; Cohen-Akenine, A.; Delabrosse, S.; Lissarrague, S.; Picard, F.P. ; Maurice, K.; Essioux, L.; Millasseau, P.; Grel, P.; Debailleul, V.; Simon, A.M.; Caterina, D.; Dufaure, I.; Malekzadeh, K.; Belova, M.; Luan, J.J.; Bouillot, M.; Sambucy, J.L.; Primas, G.; Saumier, M.; Boubkiri, N.; Martin-Saumier, S.; Nasroune, M.; Peixoto, H.; Delaye, A.; Pinchot, V.; Bastucci, M.; Guillou, S.; Chevillon, M.; Sainz-Fuertes, R.; Meguenni, S.; Aurich-Costa, J.; Cherif, D.; Gimalac, A.; Van Duijn, C.; Gauvreau, D.; Ouellette, G.; Fortier, I.; Raelson, J.; Sherbatich, T.; Riazanskaia, N.; Rogaev, E.; Raeymaekers, P.; Aerssens, J.; Konings, F.; Luyten, W.; Macciardi, F.; Sham, P.C.; Straub, R.E; Weinberger, D.R.; Cohen, N.; Cohen, D.; Ouelette, G.; Realson, J. Proc. Natl. Acad. Sci. USA, 2002, 99, 13675-13680.
80. Harrison, P.J.; Owen, M.J. Lancet, 2003, 361, 417-419.
81. Stefansson, H.; Sigurdsson, E.; Steinthorsdottir, V.; Bjornsdottir, S.; Sigmundsson, T.; Ghosh, S.; Brynjolfsson, J.; Gunnarsdottir, S.; Ivarsson, O.; Chou, T.T.; Hjaltason, O.; Birgisdottir, B.; Jonsson, H.; Gudnadottir, V.G.; Gudmundsdottir, E.; Bjornsson, A.; Ingvarsson, B.; Ingason, A.; Sigfusson, S.; Hardardottir, H.; Harvey, R.P.; Lai, D.; Zhou, M.; Brunner, D.; Mutel, V.; Gonzalo, A.; Lemke, G.; Sainz, J.; Johannesson, G.; Andresson, T.; Gudbjartsson, D.; Manolescu, A.; Frigge, M.L.; Gurney, M.E.; Kong, A.; Gulcher, J.R.; Petursson, H.; Stefansson, K. Am. J. Hum. Genet., 2002, 71, 877-892.
82. Stefansson, H.; Sarginson, J.; Kong, A.; Yates, P.; Steinthorsdottir, V. ; Gudfinnsson, E.; Gunnarsdottir, S.; Walker, N.; Petursson, H.; Crombie, C.; Ingason, A.; Gulcher, J.R.; Stefansson, K.; St Clair, D. Am. J. Hum. Genet. 2003, 72, 83-87.